TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Exotic antivenoms for NHS for emergency use

Medical equipments
pharmaceuticals and personal care products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Public Health England: "Exotic antivenoms for NHS for emergency use". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityPublic Health EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Public Health England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Public Health England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
3.3Bids / Report
71.2% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 58 active published awards; 52 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityPublic Health England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published2 Jun 2021, 22:45 BST
Last source update2 Jun 2021, 22:45 BST
Recurring procurementNot published
ClassificationMedical equipments, pharmaceuticals and personal care products
Delivery area
UK
OCIDocds-h6vhtk-02b7cc
What is being bought
Public Health England (PHE) is responsible for the provision of public health stocks of exotic antivenoms for NHS emergency use in the UK. The antivenoms are used in the event of someone being bitten or stung by an exotic venomous animal. This requirement is to source 24 different highly specialist exotic antivenoms from national and international Suppliers.
What changed
From the official release history
  1. Status changed to complete
    2 Jun 2021, 22:45 BST
  2. Official notice release published
    2 Jun 2021, 22:45 BST
  3. Buyer information updated
    2 Jun 2021, 22:45 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    This purchase will entail obtaining 24 different highly specialist exotic antivenoms from national and international Suppliers. There are 11 different suppliers, each of whom supplies a very small volume of antivenoms. PHE will communicate with suppliers and place orders following an exchange of e-mails with the supplier to confirm price per dose, shelf life and delivery timescales. The UK hub sites based across the country are required to hold specified minimum volume on likely treatment dosage. This will allows delivery to be made within 5 hours (best endeavours) from when the request is received to any hospital location within the UK.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    2 Jun 2021, 22:45 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Contract active
    Signed 25 May 2021, 00:00 BST · US$309,174
  14. Contract active
    Signed 25 May 2021, 00:00 BST · USN 309,174
  15. Contract active
    Signed 25 May 2021, 00:00 BST · USN 309,174
  16. Contract active
    Signed 25 May 2021, 00:00 BST · USN 309,174
  17. Contract active
    Signed 25 May 2021, 00:00 BST · £309,174
  18. Contract active
    Signed 25 May 2021, 00:00 BST · US$309,174
  19. Contract active
    Signed 25 May 2021, 00:00 BST · US$309,174
  20. Contract active
    Signed 25 May 2021, 00:00 BST · USN 309,174
  21. Contract active
    Signed 25 May 2021, 00:00 BST · USN 309,174
  22. Contract active
    Signed 25 May 2021, 00:00 BST · USN 309,174
  23. Contract active
    Signed 25 May 2021, 00:00 BST · USN 309,174
Commercial outcome and competition
Awards
South African Vaccine Producers (SAVP)
Not published · Not published · active
Instituto Butantan
Not published · Not published · active
Serb-labo
Not published · Not published · active
Instituto Clodomiro Picado Universidad de Costa Rica
Not published · Not published · active
MicroPharm Ltd
Not published · Not published · active
National Antivenom and Vaccine Production Centre
Not published · Not published · active
Razi Vaccine & Serum Research Institute
Not published · Not published · active
Haffkine BioPharmaceutical Corp Ltd
Not published · Not published · active
Queen Saovabha Memorial Institute
Not published · Not published · active
Centers for Disease Control
Not published · Not published · active
Seqirus
Not published · Not published · active
Contracts
Contract
US$309,174 · signed 25 May 2021, 00:00 BST · active
Contract
USN 309,174 · signed 25 May 2021, 00:00 BST · active
Contract
USN 309,174 · signed 25 May 2021, 00:00 BST · active
Contract
USN 309,174 · signed 25 May 2021, 00:00 BST · active
Contract
£309,174 · signed 25 May 2021, 00:00 BST · active
Contract
US$309,174 · signed 25 May 2021, 00:00 BST · active
Contract
US$309,174 · signed 25 May 2021, 00:00 BST · active
Contract
USN 309,174 · signed 25 May 2021, 00:00 BST · active
Contract
USN 309,174 · signed 25 May 2021, 00:00 BST · active
Contract
USN 309,174 · signed 25 May 2021, 00:00 BST · active
Contract
USN 309,174 · signed 25 May 2021, 00:00 BST · active
Bid statistics
bids: 11 (lot 1)
bids: 11 (lot 1)
bids: 11 (lot 1)
bids: 11 (lot 1)
bids: 11 (lot 1)
bids: 11 (lot 1)
bids: 11 (lot 1)
bids: 11 (lot 1)
bids: 11 (lot 1)
bids: 11 (lot 1)
bids: 11 (lot 1)
Buyer and organisations in this procedure

Public Health England

Contracting authority GB-FTS-2800
View buyer profile
  • Public Health England
    buyer

    Manor Farm Road, Porton Down, Salisbury, UK, SP2 0QT
    +44 83276919
  • Centers for Disease Control
    supplier

    Taipei City, TW
  • Haffkine BioPharmaceutical Corp Ltd
    supplier

    Mumbai, IN
  • Instituto Butantan
    supplier

    Av. Vital, BR
  • Instituto Clodomiro Picado Universidad de Costa Rica
    supplier

    San Jose, CR
  • MicroPharm Ltd
    supplier

    Carmarthenshire, UK
  • National Antivenom and Vaccine Production Centre
    supplier

    Riyadh, SA
  • Public Health England
    reviewBody

    London
  • Queen Saovabha Memorial Institute
    supplier

    Bangkok, TH
  • Razi Vaccine & Serum Research Institute
    supplier

    Kraj, IR
  • Seqirus
    supplier

    Victoria, AU
  • Serb-labo
    supplier

    Av. Louise, BE1
  • South African Vaccine Producers (SAVP)
    supplier

    2131 Sandringham, ZA
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleAs there are 11 different suppliers for this purchase, each of whom supplies a very small volume of antivenoms, Public Health England will communicate with suppliers and place orders following an exchange of e-mails with the supplier to confirm price per dose, shelf life and delivery timescales. The UK hub sites based across the country are required to hold specified minimum volume on likely treatment dosage. This allows delivery to be made within 5 hours (best endeavours) from when the request is received to any hospital location within the UK. As there are very limited suppliers in the Aativenom market we are using Reg 32(2)(b)(ii) to award the contract to 11 Suppliers, based mainly internationally. The total contract value specified per supplier cannot be confirmed, as this is dependant on different expiry date of stocks held across various sites across UK. Additionally, the selection of each antivenom will be based on the opinion of the Advisory Group. Note that under "Section V: Award of contract" no tenders were received; however, for the purpose of populating the field "11" has been entered as the contract is being awarded to 11 suppliers. A value needed to be entered as the field was mandatory. Also under the same section "Total value of the contract/lot" is appearing as £309173.57, however, the total value to be awarded during the contract term may be low as this is dependant upon factors mentioned above. A value needed to be entered as the field was mandatory.